An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (19)
  • Podcast (13)
  • Publications (652)
  • Training (6)
  • User case (13)
  • User meeting (21)
  • Webinar (119)
  • White paper (8)
Key content topics
Key audience
  • Newcomers (6)
Top cancer treatments
  • Brain and CNS (88)
  • Breast (59)
  • Gastro-intestinal (125)
  • Genito-urinary (51)
  • Gynecological (7)
  • Head and neck (133)
  • Hodgkin and Non-Hodgkin lymphoma (16)
  • Ocular (12)
  • Pediatric (100)
  • Reirradiation (12)
  • Sarcomas (18)
  • Thoracic (91)

Comparison of clinical outcome between surgical treatment and particle beam therapy for pelvic bone sarcomas: A retrospective multicenter study in Japan.

29/10/2024
/ Publications

This study from Japan reported outcomes of 116 patients with pelvic bone sarcoma treated by surgery (n=57) and particle beam (n=59, 55 carbon ion, 4 proton)...

Impact of proton versus photon adjuvant radiotherapy on overall survival in the management of skull base and spinal chordomas: a National Cancer Database analysis.

29/10/2024
/ Publications

This study reported treatment outcomes of proton or photon adjuvant therapy for chordomas of the skull base and spine. Data of 424 patients from the National...

Systematic Review and Meta-Analysis of Particle Beam Therapy versus Photon Radiotherapy for Skull Base Chordoma: TRP-Chordoma 2024.

29/10/2024
/ Publications

This analysis from Japan based on 30 selected studies reported higher 5-year progression-free survival with particle beam therapy compared to photon RT for...

Hypofractionated proton and carbon ion beam radiotherapy for sacrococcygeal chordoma (ISAC): An open label, randomized, stratified, phase II trial

29/10/2024
/ Publications

. Published in the Green Journal, this study by the Heidelberg group reported treatment outcomes of 82 patients with inoperable or incompletely resected sacral...

The cochlear dose and the age at radiotherapy predict severe hearing loss after passive scattering proton therapy and cisplatin in children with medulloblastoma.

30/10/2024
/ Publications

This study identified two risk factors associated with severe hearing loss (HL) in children with medulloblastoma treated with PSPT, which are patient age 7...

Proton Therapy in Non-Rhabdomyosarcoma Soft Tissue Sarcomas of Children and Adolescents.

30/10/2024
/ Publications

This review article examined limited clinical data of PBT for non-rhabdomyosarcoma soft tissue sarcomas (NRSTS) in pediatric and young adult populations. The...

Late-onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma.

30/10/2024
/ Publications

This study included 79 with newly diagnosed medulloblastoma treated with craniospinal RT in order to evaluate  the effect of lymphopenia during RT. Eighty-three...

Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy.

30/10/2024
/ Publications

This study reported two unusual optic nerve toxicities (CTCAE grade 3 and 4) in patients with meningioma treated with IMPT. For these two unexplained toxicity...

User meeting breakout session: IBA plans and roadmap on ConformalFLASH

07/10/2021
/ Event
/
FLASH Therapy

we still need the description

Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.

30/10/2024
/ Publications

This study by the Mayo Clinic group compared recurrence in patients with chordomas who received proton versus photon radiotherapy following resection, by using...

Pagination

  • Previous page ‹
    • Page 2
    • Current page 3
    • Page 4
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies